Insider · CIK 0001578770
Matthew J D'Onofrio
Files at EVOK (Evoke Pharma Inc). First filing -, latest -.
Matthew J D'Onofrio files SEC Form 4 as CEO and director at EVOK (Evoke Pharma Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew J D'Onofrio has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | EVOK Evoke Pharma Inc | UTender of shares Common Stock | -15,509 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -64,840 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,000 | - | - | 0 | Dec 17, 2025 |
| Mar 21, 2025 | EVOK Evoke Pharma Inc | AGrant or award Common Stock | +1,000 | $2.80 | $2,797 | 9,820 | Mar 24, 2025 |
| Feb 28, 2025 | EVOK Evoke Pharma Inc | AGrant or award Common Stock | +6,849 | $3.65 | $25k | 8,820 | Mar 3, 2025 |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | AGrant or award Stock Option (Right to Buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Jan 29, 2025 |
Questions about Matthew J D'Onofrio
Answered from the filings on this page, as of the latest one.
Is Matthew J D'Onofrio buying or selling?
Matthew J D'Onofrio has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew J D'Onofrio's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew J D'Onofrio has 0.
Where does Matthew J D'Onofrio file Form 4?
Matthew J D'Onofrio has filed Form 4 at EVOK (Evoke Pharma Inc) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.